Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

COVID-19

Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

Sinopharm to Transfer Six Vaccine Companies (Including Two Covid-19 Vaccines) to Beijing Tiantan Bio

Jiangxi Jemincare to Start US Trial of SARS-CoV-2 Neutralizing Antibody 

Sinovac Raises Production of COVID-19 Vaccine to 2 Billion Doses Per Year

Kintor's Androgen Agonist Reduces COVID-19 Mortality in Hospitals by 92%

Kintor OK'd to Start US Trial of Androgen Receptor Antagonist for COVID-19

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021